Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.42 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.42 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.41 |
| ▸ | TMEM97 | Q5BJF2 | 3/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526756 | 0.86 | NPSR1 (0.39) | PDK1PDK2PDK3PDK4AADAT | |
| SCHEMBL33526322 | 0.79 | GAA (0.44) | POLBTSHRNPSR1 | |
| SCHEMBL4764757 | 0.69 | AADAT (0.46) | AADATSIGMAR1TMEM97TSHRNPSR1 | |
| SCHEMBL4764747 | 0.69 | AADAT (0.46) | AADATSIGMAR1TMEM97TSHRNPSR1 | |
| Hydrochloric Acid SCHEMBL34467091 | 0.68 | POLB (0.46) | POLBTSHR | |
| Hydrochloric Acid SCHEMBL33527160 | 0.68 | POLB (0.46) | POLBTSHR | |
| Trifluoroacetic Acid SCHEMBL33527477 | 0.68 | POLB (0.41) | PARP1POLB | |
| SCHEMBL16794552 | 0.67 | SMN1; SMN2 (0.53) | SIGMAR1TMEM97NPSR1 | |
| SCHEMBL16806475 | 0.67 | CARM1 (0.42) | POLBTSHRNPSR1 | |
| Hydrochloric Acid SCHEMBL31753682 | 0.67 | POLB (0.42) | POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | PDK1 1803/4885PDK2 3115/4885PDK3 2425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.